Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 7, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-07
DOI
10.1186/s40425-019-0751-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of bone marrow-derived signals on NK cell development and functional maturation
- (2018) Helena Stabile et al. CYTOKINE & GROWTH FACTOR REVIEWS
- The bone marrow is patrolled by NK cells that are primed and expand in response to systemic viral activation
- (2018) Idan Milo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Implication of Interleukin-12/15/18 and Ruxolitinib in the Phenotype, Proliferation, and Polyfunctionality of Human Cytokine-Preactivated Natural Killer Cells
- (2018) Iñigo Terrén et al. Frontiers in Immunology
- Translating the anti-myeloma activity of Natural Killer cells into clinical application
- (2018) Cinzia Fionda et al. CANCER TREATMENT REVIEWS
- High expression levels of IP10/CXCL10 are associated with modulation of the natural killer cell compartment in multiple myeloma
- (2017) Giovanni Bernardini et al. LEUKEMIA & LYMPHOMA
- Natural killer cell-mediated immunosurveillance of human cancer
- (2017) Karl-Johan Malmberg et al. SEMINARS IN IMMUNOLOGY
- Neoplastic plasma cells generate an inflammatory environment within bone marrow and markedly alter the distribution of T cells between lymphoid compartments
- (2017) Oliver C. Goodyear et al. Oncotarget
- Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation
- (2017) Markus Granzin et al. Frontiers in Immunology
- Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs
- (2017) Gianfranco Pittari et al. Frontiers in Immunology
- Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
- (2017) Alessandra Zingoni et al. Frontiers in Immunology
- Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
- (2017) Veronika Kremer et al. Journal for ImmunoTherapy of Cancer
- Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?
- (2016) Jacalyn Rosenblatt et al. BLOOD
- Monokine induced by interferon gamma (MIG/CXCL9) is an independent prognostic factor in newly diagnosed myeloma
- (2016) Arnold Bolomsky et al. LEUKEMIA & LYMPHOMA
- Targeting natural killer cells in cancer immunotherapy
- (2016) Camille Guillerey et al. NATURE IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
- (2016) Rizwan Romee et al. Science Translational Medicine
- Harnessing NK Cell Memory for Cancer Immunotherapy
- (2016) Todd A. Fehniger et al. TRENDS IN IMMUNOLOGY
- PD1 blockade enhances cytotoxicity of in vitro expanded natural killer cells towards myeloma cells
- (2016) Yanan Guo et al. Oncotarget
- Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy
- (2016) Maryann E. Mikucki et al. OncoImmunology
- Natural killer cell recognition of in vivo drug-induced senescent multiple myeloma cells
- (2016) Fabrizio Antonangeli et al. OncoImmunology
- Novel treatment strategy with autologous activated and expanded natural killer cells plus anti-myeloma drugs for multiple myeloma
- (2016) Alejandra Leivas et al. OncoImmunology
- Multiple Myeloma Impairs Bone Marrow Localization of Effector Natural Killer Cells by Altering the Chemokine Microenvironment
- (2015) A. Ponzetta et al. CANCER RESEARCH
- Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors
- (2015) S. Ganghammer et al. HAEMATOLOGICA
- Natural Killer Cell Memory
- (2015) Timothy E. O’Sullivan et al. IMMUNITY
- Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
- (2015) Nadja Müller et al. JOURNAL OF IMMUNOTHERAPY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
- (2015) Richard W. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- Combined CXCR3/CXCR4 measurements are of high prognostic value in chronic lymphocytic leukemia due to negative co-operativity of the receptors
- (2015) S. Ganghammer et al. HAEMATOLOGICA
- Expansion and Homing of Adoptively Transferred Human Natural Killer Cells in Immunodeficient Mice Varies with Product Preparation and In Vivo Cytokine Administration: Implications for Clinical Therapy
- (2014) Jeffrey S. Miller et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
- (2014) Erik Wennerberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor Su/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
- (2013) W. Xu et al. CANCER RESEARCH
- Nfil3-independent lineage maintenance and antiviral response of natural killer cells
- (2013) Matthew A. Firth et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CX3CR1 Regulates the Maintenance of KLRG1+ NK Cells into the Bone Marrow by Promoting Their Entry into Circulation
- (2013) A. Ponzetta et al. JOURNAL OF IMMUNOLOGY
- Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow
- (2013) Giovanni Bernardini et al. Frontiers in Immunology
- Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry
- (2012) A. M. Mulligan et al. CLINICAL CANCER RESEARCH
- The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses
- (2012) Russell K. Pachynski et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors
- (2012) Jing Ni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A phase II, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of MDX-1100, a fully human anti-CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis
- (2011) Michael Yellin et al. ARTHRITIS AND RHEUMATISM
- Sequential desensitization of CXCR4 and S1P5 controls natural killer cell trafficking
- (2011) K. Mayol et al. BLOOD
- The Interactions of Multiple Cytokines Control NK Cell Maturation
- (2010) J. Brady et al. JOURNAL OF IMMUNOLOGY
- Cytokine-induced memory-like natural killer cells
- (2009) Megan A. Cooper et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets
- (2008) G. Bernardini et al. BLOOD
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started